Literature DB >> 16696836

Electroconvulsive therapy: an effective therapy of medication-resistant bipolar disorder.

Pascal Sienaert1, Joseph Peuskens.   

Abstract

OBJECTIVES: We report our experience with a medication-refractory patient with bipolar I disorder, who remained clinically stable under continuation electroconvulsive therapy (C-ECT). We found ECT to be effective in providing functionality for a patient when various medications had failed. METHODS AND
RESULTS: A 53-year-old woman with a 31-year history of recurrent manic and depressive episodes poorly responsive to medications warranted an ECT trial. Remission was achieved after 12 treatments and C-ECT at weekly intervals was used as maintenance therapy. C-ECT was continued for 37 months and 85 treatments, and discontinued when anesthetic difficulties precluded further treatment. Three months after the last ECT, she was readmitted in a severe manic relapse. Restarting ECT caused rapid remission. There are no signs of cognitive deterioration during C-ECT.
CONCLUSION: Long-term C-ECT is an effective and safe prophylactic treatment in individual treatment-resistant patients with bipolar disorder.

Entities:  

Mesh:

Year:  2006        PMID: 16696836     DOI: 10.1111/j.1399-5618.2006.00317.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  9 in total

Review 1.  Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature.

Authors:  Georgios Petrides; Kristen G Tobias; Charles H Kellner; Matthew V Rudorfer
Journal:  Neuropsychobiology       Date:  2011-07-29       Impact factor: 2.328

2.  The study protocol of the Norwegian randomized controlled trial of electroconvulsive therapy in treatment resistant depression in bipolar disorder.

Authors:  Ute Kessler; Arne E Vaaler; Helle Schøyen; Ketil J Oedegaard; Per Bergsholm; Ole A Andreassen; Ulrik F Malt; Gunnar Morken
Journal:  BMC Psychiatry       Date:  2010-02-23       Impact factor: 3.630

Review 3.  Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine-Immune Therapeutic Mechanisms and Clinical Implications.

Authors:  Milagros Rojas; Daniela Ariza; Ángel Ortega; Manuel E Riaño-Garzón; Mervin Chávez-Castillo; José Luis Pérez; Lorena Cudris-Torres; María Judith Bautista; Oscar Medina-Ortiz; Joselyn Rojas-Quintero; Valmore Bermúdez
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

Review 4.  Catatonia in autism: implications across the life span.

Authors:  Angelina Kakooza-Mwesige; Lee E Wachtel; Dirk M Dhossche
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-04-21       Impact factor: 4.785

Review 5.  Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT.

Authors:  Nancy A Payne; Joan Prudic
Journal:  J Psychiatr Pract       Date:  2009-09       Impact factor: 1.325

6.  The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features.

Authors:  Giulio Perugi; Pierpaolo Medda; Cristina Toni; Michela Giorgi Mariani; Chiara Socci; Mauro Mauri
Journal:  Curr Neuropharmacol       Date:  2017-04       Impact factor: 7.363

7.  Electroconvulsive Therapy (ECT) in Bipolar Disorder Patients with Ultra-Rapid Cycling and Unstable Mixed States.

Authors:  Sergey Mosolov; Christoph Born; Heinz Grunze
Journal:  Medicina (Kaunas)       Date:  2021-06-15       Impact factor: 2.430

Review 8.  Acute and long-term treatment of mania.

Authors:  Eduard Vieta; Jose Sanchez-Moreno
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

9.  Chlorpromazine as Prophylaxis for Bipolar Disorder with Treatment- and Electroconvulsive Therapy-Refractory Mania: Old Horse, New Trick.

Authors:  Tamonud Modak; Saurabh Kumar; Arghya Pal; Rishab Gupta; Raman Deep Pattanayak; Sudhir Kumar Khandelwal
Journal:  Indian J Psychol Med       Date:  2017 Jul-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.